Annual D&A
$5.77 M
+$442.40 K+8.30%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual depreciation & amortization is $5.77 million, with the most recent change of +$442.40 thousand (+8.30%) on December 31, 2023.
- During the last 3 years, CPIX annual D&A has risen by +$1.02 million (+21.52%).
- CPIX annual D&A is now at all-time high.
Performance
CPIX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.40 M
-$23.40 K-1.64%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly depreciation & amortization is $1.40 million, with the most recent change of -$23.40 thousand (-1.64%) on September 30, 2024.
- Over the past year, CPIX quarterly D&A has increased by +$42.50 thousand (+3.13%).
- CPIX quarterly D&A is now -15.27% below its all-time high of $1.65 million, reached on March 31, 2022.
Performance
CPIX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$5.62 M
-$85.60 K-1.50%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM depreciation & amortization is $5.62 million, with the most recent change of -$85.60 thousand (-1.50%) on September 30, 2024.
- Over the past year, CPIX TTM D&A has dropped by -$150.10 thousand (-2.60%).
- CPIX TTM D&A is now -4.64% below its all-time high of $5.89 million, reached on September 30, 2022.
Performance
CPIX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
CPIX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +8.3% | +3.1% | -2.6% |
3 y3 years | +21.5% | +30.5% | +18.2% |
5 y5 years | +93.5% | +24.5% | +27.6% |
CPIX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +25.3% | -15.3% | +173.9% | -4.6% | +22.0% |
5 y | 5-year | at high | +31.0% | -15.3% | +173.9% | -4.6% | +27.6% |
alltime | all time | at high | >+9999.0% | -15.3% | +7049.0% | -4.6% | >+9999.0% |
Cumberland Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.40 M(-1.6%) | $5.62 M(-1.5%) |
Jun 2024 | - | $1.42 M(-0.8%) | $5.71 M(-1.3%) |
Mar 2024 | - | $1.44 M(+5.7%) | $5.78 M(+0.1%) |
Dec 2023 | $5.77 M(+8.3%) | $1.36 M(-8.6%) | $5.77 M(+17.2%) |
Sep 2023 | - | $1.49 M(-0.7%) | $4.92 M(-1.2%) |
Jun 2023 | - | $1.50 M(+4.8%) | $4.98 M(-2.4%) |
Mar 2023 | - | $1.43 M(+179.2%) | $5.10 M(-4.2%) |
Dec 2022 | $5.33 M(+15.7%) | $511.50 K(-66.9%) | $5.33 M(-9.6%) |
Sep 2022 | - | $1.54 M(-4.6%) | $5.89 M(+8.7%) |
Jun 2022 | - | $1.62 M(-2.1%) | $5.42 M(+7.8%) |
Mar 2022 | - | $1.65 M(+53.5%) | $5.03 M(+9.3%) |
Dec 2021 | $4.61 M(-3.0%) | $1.08 M(+0.3%) | $4.61 M(-3.1%) |
Sep 2021 | - | $1.07 M(-12.6%) | $4.75 M(-2.4%) |
Jun 2021 | - | $1.23 M(+0.0%) | $4.87 M(+0.9%) |
Mar 2021 | - | $1.23 M(+0.3%) | $4.82 M(+1.6%) |
Dec 2020 | $4.75 M(+7.8%) | $1.22 M(+2.8%) | $4.75 M(+2.1%) |
Sep 2020 | - | $1.19 M(+0.6%) | $4.65 M(+1.9%) |
Jun 2020 | - | $1.18 M(+2.6%) | $4.56 M(+1.9%) |
Mar 2020 | - | $1.15 M(+2.4%) | $4.48 M(+1.7%) |
Dec 2019 | $4.40 M(+47.7%) | $1.13 M(+1.9%) | $4.40 M(+6.0%) |
Sep 2019 | - | $1.10 M(+0.6%) | $4.15 M(+10.4%) |
Jun 2019 | - | $1.10 M(+2.0%) | $3.76 M(+11.8%) |
Mar 2019 | - | $1.08 M(+23.0%) | $3.37 M(+12.8%) |
Dec 2018 | $2.98 M(+12.6%) | $874.70 K(+22.6%) | $2.98 M(+7.2%) |
Sep 2018 | - | $713.30 K(+1.7%) | $2.78 M(+2.0%) |
Jun 2018 | - | $701.70 K(+1.3%) | $2.73 M(+1.8%) |
Mar 2018 | - | $693.00 K(+2.9%) | $2.68 M(+1.2%) |
Dec 2017 | $2.65 M(+10.5%) | $673.60 K(+2.1%) | $2.65 M(+2.4%) |
Sep 2017 | - | $659.90 K(+1.1%) | $2.59 M(+1.8%) |
Jun 2017 | - | $652.80 K(-1.3%) | $2.54 M(+2.6%) |
Mar 2017 | - | $661.50 K(+8.1%) | $2.48 M(+3.3%) |
Dec 2016 | $2.40 M(+6.7%) | $611.90 K(-0.3%) | $2.40 M(+1.8%) |
Sep 2016 | - | $613.60 K(+4.1%) | $2.35 M(+3.5%) |
Jun 2016 | - | $589.30 K(+1.2%) | $2.28 M(+0.3%) |
Mar 2016 | - | $582.10 K(+2.3%) | $2.27 M(+0.9%) |
Dec 2015 | $2.25 M | $568.90 K(+6.4%) | $2.25 M(-1.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2015 | - | $534.90 K(-8.1%) | $2.28 M(-2.1%) |
Jun 2015 | - | $581.80 K(+3.7%) | $2.33 M(+8.2%) |
Mar 2015 | - | $561.20 K(-7.4%) | $2.16 M(+8.3%) |
Dec 2014 | $1.99 M(+52.8%) | $606.00 K(+3.9%) | $1.99 M(+12.5%) |
Sep 2014 | - | $583.40 K(+44.0%) | $1.77 M(+18.5%) |
Jun 2014 | - | $405.10 K(+2.5%) | $1.49 M(+6.1%) |
Mar 2014 | - | $395.10 K(+2.7%) | $1.41 M(+8.0%) |
Dec 2013 | $1.30 M(+44.4%) | $384.80 K(+25.3%) | $1.30 M(+12.8%) |
Sep 2013 | - | $307.00 K(-3.9%) | $1.15 M(+7.8%) |
Jun 2013 | - | $319.50 K(+10.0%) | $1.07 M(+9.8%) |
Mar 2013 | - | $290.50 K(+22.4%) | $974.90 K(+8.1%) |
Dec 2012 | $901.60 K(-13.3%) | $237.30 K(+6.3%) | $901.70 K(-0.2%) |
Sep 2012 | - | $223.20 K(-0.3%) | $903.30 K(-5.3%) |
Jun 2012 | - | $223.90 K(+3.0%) | $954.30 K(-4.1%) |
Mar 2012 | - | $217.30 K(-9.0%) | $995.40 K(-4.3%) |
Dec 2011 | $1.04 M(+6.3%) | $238.90 K(-12.9%) | $1.04 M(-1.5%) |
Sep 2011 | - | $274.20 K(+3.5%) | $1.06 M(+1.4%) |
Jun 2011 | - | $265.00 K(+1.0%) | $1.04 M(+3.2%) |
Mar 2011 | - | $262.30 K(+3.0%) | $1.01 M(+3.2%) |
Dec 2010 | $978.40 K(+19.8%) | $254.70 K(-2.0%) | $978.30 K(+4.7%) |
Sep 2010 | - | $260.00 K(+11.9%) | $934.60 K(+6.0%) |
Jun 2010 | - | $232.30 K(+0.4%) | $881.80 K(+3.5%) |
Mar 2010 | - | $231.30 K(+9.6%) | $851.80 K(+4.3%) |
Dec 2009 | $816.50 K(+3.8%) | $211.00 K(+1.8%) | $816.60 K(+1.8%) |
Sep 2009 | - | $207.20 K(+2.4%) | $802.50 K(+1.3%) |
Jun 2009 | - | $202.30 K(+3.2%) | $792.10 K(+0.6%) |
Mar 2009 | - | $196.10 K(-0.4%) | $787.60 K(+0.1%) |
Dec 2008 | $786.60 K(+3.2%) | $196.90 K(+0.1%) | $786.60 K(+33.4%) |
Sep 2008 | - | $196.80 K(-0.5%) | $589.70 K(+50.1%) |
Jun 2008 | - | $197.80 K(+1.4%) | $392.90 K(+101.4%) |
Mar 2008 | - | $195.10 K(+3.2%) | $195.10 K(-66.8%) |
Dec 2007 | $762.20 K(+29.7%) | - | - |
Dec 2006 | $587.70 K(+998.5%) | $189.00 K(+0.4%) | $587.70 K(+47.4%) |
Sep 2006 | - | $188.30 K(-1.3%) | $398.70 K(+89.5%) |
Jun 2006 | - | $190.80 K(+873.5%) | $210.40 K(+973.5%) |
Mar 2006 | - | $19.60 K | $19.60 K |
Dec 2005 | $53.50 K | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual D&A year-on-year change?
- What is Cumberland Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly D&A year-on-year change?
- What is Cumberland Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM D&A year-on-year change?
What is Cumberland Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CPIX is $5.77 M
What is the all time high annual D&A for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual depreciation & amortization is $5.77 M
What is Cumberland Pharmaceuticals annual D&A year-on-year change?
Over the past year, CPIX annual depreciation & amortization has changed by +$442.40 K (+8.30%)
What is Cumberland Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CPIX is $1.40 M
What is the all time high quarterly D&A for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly depreciation & amortization is $1.65 M
What is Cumberland Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CPIX quarterly depreciation & amortization has changed by +$42.50 K (+3.13%)
What is Cumberland Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CPIX is $5.62 M
What is the all time high TTM D&A for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM depreciation & amortization is $5.89 M
What is Cumberland Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CPIX TTM depreciation & amortization has changed by -$150.10 K (-2.60%)